UBS Maintains Neutral on RXO, Lowers Price Target to $23

RXO, Inc. Common Stock

RXO, Inc. Common Stock

RXO

0.00

UBS analyst Thomas Wadewitz maintains RXO (NYSE: RXO) with a Neutral and lowers the price target from $26 to $23.